Resources
U-M Funding Opportunities
Great Lakes Discovery
Translational Drug Discovery Funding
U-M and Deerfield Management created Great Lakes Discovery, a new alliance to commercialize U-M therapeutic projects that hold promise in developing potentially life-saving drugs and disease treatments. Through Great Lakes Discovery, Deerfield has committed up to $130 million in funding to support translational research and development efforts for promising U-M therapeutic projects. Projects selected by Great Lakes Discovery will be provided funding and operational support by Deerfield for a development plan aimed at achieving Investigational New Drug (IND) readiness.
Rogel Cancer Center
Rogel Cancer Center Funding
The Rogel Cancer Center offers a variety of funding mechanisms on a rolling basis and curates an extensive list of extramural funding opportunities.
Forbes Institute for Cancer Discovery Grant
Fund team science awards based on competitive peer review. Inter-school collaborations are encouraged.
Michigan Center for Therapeutic Innovation (MCTI)
Therapeutic Innovation Fund
A five-year, $2.5 million fund created in 2016 to accelerate the discovery and translation of therapeutic candidates at the University of Michigan
Fast Forward Medical Innovation
Kickstart Early-Stage Funding
A statewide program that accelerates the transfer of technologies from Michigan’s institutions of higher education to the private sector for commercialization.
TRAC Mid-Stage Funding
The awards provide mid-stage, translational research funding and resources for proof-of-concept and late-stage translational studies with a high potential of commercial success.
TRAC Mid-Stage Funding
The awards provide mid-stage, translational research funding and resources for proof-of-concept and late-stage translational studies with a high potential of commercial success.
TRAC Mid-Stage Funding
The awards provide mid-stage, translational research funding and resources for proof-of-concept and late-stage translational studies with a high potential of commercial success.
Massey Foundation Traumatic Brain Injury Fund
Funds the development of diagnostic, device, therapeutic, or health IT solutions that address the initial “golden hours” of care after severe TBI (generally the first 48 hours).
FFMI Personalized Funding Consultation
If you’re a U-M Medical School researcher with a proof-of-concept technology, an early-stage biomedical venture, or you’re exploring commercialization opportunities, a personalized funding consultation with an FFMI commercialization expert can help you plan, secure funding, and advance your innovation.
Michigan Institute for Clinical & Health Research (MICHR)
MICHR Funding
MICHR offers a variety of funding opportunities in basic, translational, and clinical research. This includes support and training in preparing large, extramural grants.
College of Engineering
Michigan Biomedical Venture Fund (MBVF)
A funding vehicle designed to advance the process of transitioning commercially viable biomedical and healthcare projects to market
Biomedical Engineering
Coulter Translational Research Partnership
A commercialization fund that seeks to accelerate the development of university technologies into new products to improve health care.